Elanco Animal Health Incorporated reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 1,035 million compared to USD 985 million a year ago. Net loss was USD 141 million compared to USD 55 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 0.29 compared to USD 0.11 a year ago.
For the full year, sales was USD 4,417 million compared to USD 4,411 million a year ago. Net loss was USD 1,231 million compared to USD 78 million a year ago. Basic loss per share from continuing operations was USD 2.5 compared to USD 0.16 a year ago. Diluted loss per share from continuing operations was USD 2.5 compared to USD 0.16 a year ago.